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Global gene expression patterns can provide comprehensive molecular portraits of biologic diversity and complex
disease states, but understanding the physiologic meaning and genetic basis of the myriad gene expression
changes have been a challenge. Several new analytic strategies have now been developed to improve the inter-
pretation of microarray data. Because genes work together in groups to carry out specific functions, deﬁning the
unit of analysis by coherent changes in biologically meaningful sets of genes, termed modules, improves our
understanding of the biological processes underlying the gene expression changes. The gene module approach
has been used in exploratory discovery of defective oxidative phosphorylation in diabetes mellitus and also has
allowed deﬁnitive hypothesis testing on a genomic scale for the relationship between wound healing and cancer
and for the oncogenic mechanism of cyclin D. To understand the genetic basis of global gene expression patterns,
computational modeling of regulatory networks can highlight key regulators of the gene expression changes,
and many of these predictions can now be experimentally validated using global chromatin-immunoprecipitation
analysis.
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Biological research has been revolutionized by the com-
plete genome sequences of hundreds of organisms, giving
rise to the new science of genomics. Microarray analysis
takes advantage of the vast amount of sequence informa-
tion and allows investigators to examine alterations in the
gene expression of thousands of genes simultaneously in a
single experiment. The basic experimental setup and pro-
cedures in standard microarray experiments have been
discussed in several excellent reviews (Brown and Botstein,
1999; Churchill, 2002). Global gene expression patterns
have the potential to better define biologic phenomena and
human disease states at the molecular level. For example,
based on the differential expression of hundreds to thou-
sands of genes, many cancers previously thought to be
homogenous are now recognized to consist of distinct mo-
lecular subtypes and are often associated with significantly
different clinical outcomes (Golub et al, 1999; Alizadeh et al,
2000). Microarray analysis have also been applied to several
dermatologic diseases, including melanoma, mycosis fun-
goides, cutaneous B cell lymphoma, psoriasis, atopic der-
matitis, alopecia areata, and scleroderma (Bittner et al,
2000; Clark et al, 2000; Bowcock et al, 2001; Oestreicher
et al, 2001; Zhou et al, 2001, 2003; Carroll et al, 2002;
Nomura et al, 2003; Storz et al, 2003; Tracey et al, 2003;
Whitfield et al, 2003).
Making biological sense out of the laundry list of up- and
down-regulated genes from microarray experiments is,
however, often difficult. How does one interpret what bio-
logical processes underlie the expression changes of hun-
dreds to thousands of genes, and which one of the myriad
genes is the key regulator that allows the investigator to
experimentally manipulate the underlying biology? We will
discuss two new bioinformatic strategies that have been
developed to improve interpretation of microarray data:
gene module and regulatory network analysis. These meth-
ods aim to identify the relevant pathways and key regulators
from microarray data of any biologic process or disease
state. Resources for these methods are listed in Table I.
In the Beginning
Traditional microarray analysis aims to identify individual
genes that are consistently up- or down-regulated among
samples that are known to be different, or to identify con-
sistent variation across a set of heterogeneous samples.
Therefore, the expression value of each gene across all
samples is analyzed with t tests or analysis of variance; the
significance of the difference in expression is adjusted for
the number of times the statistical test is done. (If 10,000
genes were examined, 500 genes should be significant at
p¼o0.05 based on chance alone. Therefore, more strin-
gent criteria or a calculation of false discovery rate given the
sample size are necessary. If 1000 genes were identified
at p¼o0.001, the false discovery rate will be (10,000 
0.001)/1000¼ 0.01). Investigators also typically focus on
genes that change in expression beyond a threshold level
(typically 2-fold) relative to the control sample. Investigators
then examine the selected genes to develop hypotheses
Abbreviations: cDNA, complementary DNA; CDK, cyclin-depend-
ent kinase; ChIP-chip, chromatin-immunoprecipitation followed by
microarray analysis
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about the biological mechanism behind the disease proc-
ess. For example, Clark et al found the RhoC gene, a
GTPase that regulates cytoskeletal organization, to be up-
regulated in melanoma metastases relative to the primary
tumor. They subsequently demonstrated that metastasis
was enhanced by RhoC overexpression and inhibited with
dominant-negative RhoC (Clark et al, 2000). Tracey et al
(2003) identified genes in the TNF signaling pathway to be
preferentially expressed in mycosis fungoides lesions rela-
tive to other inflammatory disorders. Although these gene-
by gene analysis methods are powerful and will continue to
generate new biological insights, new bioinformatic strate-
gies have been developed to learn more from microarray
data.
Gene Modules
Gene module analysis is based on the simple idea that
genes typically work together in groups, such as in enzyma-
tic pathways or regulatory cascades. Thus, the unit of
analysis in a microarray experiment should be groups of
functionally related genes, termed modules, and one as-
signs more significance to a group of genes having coor-
dinate regulation than just one member of a group being
regulated in the experiment (Mootha et al, 2003; Segal et al,
2004). Using previous biological knowledge, gene modules
can be defined by sets of genes that are members of the
same biological pathway, have a shared structural motif, are
expressed in a specific tissue, or are induced by a specific
stimulus. A biological pathway is typically defined by two
gene modules: one for the up-regulated genes in the path-
way and one for the down-regulated genes. Gene modules
can have different numbers of member genes, and each
gene can belong to multiple modules. In a microarray ex-
periment, gene module analysis searches for coordinate
regulation of genes that belong to these a priori defined
gene modules; a statistical test is performed for each mod-
ule relative to all other genes on the microarray to calculate
whether the degree of coordinate regulation is more than
one would expect by chance.
The gene module approach has several advantages over
our current gene-by-gene methods of analysis. First, gene
module analysis can detect meaningful expression patterns
that would otherwise go undetected (Fig 1). Coordinated
small magnitude regulation of gene expression of many
genes in the same pathway can be biologically more im-
portant than a large magnitude change that is discordant
with other members of the pathway; however, this type of
regulation is often missed by the gene-by-gene approach.
Moreover, the large number of genes examined in the gene-
by-gene approach necessitates significant penalties for
multiple hypothesis testing; many biologically meaningful
changes can be missed. Gene module analysis takes ad-
vantage of the power of groups of genes to detect those
genes that have biologically significant, albeit subtle, ex-
pression changes. Secondly, because modules are defined
by groups of genes known to share certain biological func-
tion or characteristics, defining the unit of analysis by mod-
ules improve the investigator’s mechanistic interpretation of
the biology underlying the gene expression changes. For
example, modules can consist of groups of genes previ-
ously found to be coordinately regulated in other microarray
experiments. In this way, gene module analysis allows one
to compare each new microarray experiment to every pre-
viously performed experiment to identify commonalities and
unifying mechanisms. By analogy with sequence searches
where a newly cloned gene is compared to genes in the
database for blocks of sequence similarity, gene module
analysis allows one to discover features of gene expression
patterns that have been observed in other microarray ex-
periments.
It should be noted that the strength of gene module
analysis, which lies in previous biological knowledge, is also
Table I. Informatic resources on the Internet
Tool Function Web site
Cluster Performs hierarchical clustering. Genes and samples in
microarray experiments are organized by similarity.
http://rana.lbl.gov/EisenSoftware.htm
GenePattern Analysis and data visualization software from Broad Institute at
MIT. Performs sequence and microarray analysis, including
Kolmogorov–Smirnov score test.
http://www.broad.mit.edu/cancer/software/
genepattern/
GeneXpress (i) Implements Gene Module Map. http://robotics.stanford.edu/erans/cancer/
(ii) Identify enriched transcription factor binding sites in the
promoters of gene modules.
(iii) Implements module networks.
Gene
Ontology Term
Finder
Gene Ontology classifies each gene in the genome using a
controlled vocabulary. Tool identified enriched GO terms within
groups of select genes.
http://search.cpan.org/dist/GO-TermFinder/
GeneHopping Identifies sets of co-regulated genes between organisms and
provides visualization of modules.
http://barkai-serv.weizmann.ac.il/Software/
GeneHopping/Hopping.html
Onto-Tools Web-based program to (i) identify GO term enrichment, (ii) map
probes among different array platforms, (iii) retrieve annotations of
specific genes.
http://vortex.cs.wayne.edu:8080/ontoexpress/
servlet/UserInfo
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its limitation. Many genes in the human genome have un-
known or poorly defined function and thus are not included
in gene modules. Many biological processes have not been
examined by previous genetic or expression profiling ex-
periments, and thus gene modules that correspond to these
processes need to be experimentally defined. In addition,
poorly defined gene modules may result in flawed data in-
terpretation; module analysis needs to start from primary
expression data that has sound experimental design and
good technical quality. High quality expression data are
derived from well-defined biological samples, have ade-
quate median intensity signal, and are validated with rep-
licates and other independent methods such as RT-PCR.
Keeping these caveats in mind, we highlight several exam-
ples to illustrate the power and diverse uses of gene module
analysis.
Three Examples of Gene Module Analysis
At its simplest level, gene module analysis is no more than
known gene expression patterns that serve as positive
controls to interpret new data. Whitfield et al (2003) com-
pared global gene expression patterns of skin from patients
with systemic sclerosis and normal volunteers. Interestingly,
the gene expression pattern of clinically uninvolved skin
from scleroderma patients was more similar to that of clin-
ically involved skin of scleroderma patients than skin from
normal volunteers. Because skin tissue is composed of
various types of cells, the authors determined the contri-
bution of each cell type to the pathologic gene expression
pattern in scleroderma using a rudimentary form of module
analysis. Whitfield et al determined the global gene expres-
sion patterns of 11 different cell lines, including epithelial
cells, fibroblasts, endothelial cells, smooth muscle cells,
and B lymphocytes, to construct canonical gene expression
patterns of each cell type. Comparison with the scleroder-
ma gene expression pattern demonstrated a strong contri-
bution of the B lymphocyte signature, suggesting a potential
role for B cells in the pathogenesis of scleroderma (Whitfield
et al, 2003). Consistent with this result, B cells also appear
to have a pathogenic role in the tight-skin mouse model of
scleroderma (Saito et al, 2002). These studies support the
idea that rituximab, an anti-CD20 monoclonal antibody
which targets B cells, may be useful in the treatment of
scleroderma.
In the second example, Mootha et al (2003) pioneered a
type of gene module analysis (which they termed gene set
enrichment analysis or GSEA) to discover the biological
pathways underlying type II diabetes mellitus. They com-
pared global gene expression patterns of skeletal muscle
biopsies from individuals with normal glucose tolerance,
impaired glucose tolerance, and type II diabetes mellitus.
After rigorous statistical tests on a gene-by-gene basis (and
suffering the concomitant multiple hypothesis testing pen-
alty), they found no single gene with a significant difference
in expression. Mootha et al noticed, however, that many
genes that showed the most consistent changes encoded
enzymes involved in mitochondrial oxidative phosphorylat-
ion. To test the significance of this observation, the authors
implemented gene module analysis by constructing 149
modules of various metabolic pathways or co-regulated
genes. The authors sorted all genes on the microarray into a
ranked list, from the one best able to distinguish diabetes
versus normal to the least informative. They then asked if
the distribution of genes on this list is surprising given the
membership of genes in modules.
Specifically, the authors applied the Kolmogorov–Smir-
nov running sum statistic: Beginning with the gene at the
top of the ranked list, the running sum increases when a
gene that is a member of the gene set is encountered and
decreases otherwise. The maximum enrichment score is
the greatest positive deviation of the running sum across all
genes. To determine the statistical significance of the max-
imum enrichment score and validate that the results are
unlikely to arise by chance alone, permutation testing is
performed, comparing the maximum enrichment score us-
ing the actual data to that seen in each of 1000 permuted
data sets.
GSEA revealed that a module of genes involved in oxi-
dative phosphorylation was significantly downregulated in
patients with diabetes. Each gene in the oxidative phos-
phorylation gene module was transcriptionally down
regulated by roughly only 20%, and thus was not clearly
detected at the individual gene level. Independent work by
Shulman and colleagues using magnetic resonance
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Figure 1
Gene module analysis can detect subtle changes in gene expres-
sion from microarray experiments. Each line within the left-hand box
labeled ‘‘Array’’ represents a gene positioned along the y-axis accord-
ing to fold change in expression relative to a reference in a microarray
experiment. ‘‘Module 1’’ and ‘‘Module 2’’ are a priori defined sets of
genes that are co-activated in two distinct biological pathways; their
respective boxes contain their members arranged according to their
relative fold change in expression in the ‘‘Array’’ and labeled with the
colors orange and green, respectively. Individual gene approaches
would detect the two highly upregulated genes in ‘‘Module 1’’ but
would not detect any significant change in any of the genes in ‘‘Module
2’’. Gene module analysis, however, demonstrates that ‘‘Module 2’’
may be more significant than ‘‘Module 1’’ in this experiment because
‘‘Module 1’’ has genes that are both upregulated and downregulated,
whereas all of the genes in ‘‘Module 2’’ are upregulated.
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spectroscopy confirmed that defective mitochondrial oxi-
dative phosphorylation is strongly associated with glucose
intolerance and appears to be a strong predictor for devel-
opment of diabetes (Petersen et al, 2003).
In addition to looking at whether each gene module is
significantly regulated in the experiment, gene module anal-
ysis also examines which particular genes within a module
are contributing to the regulation. This information can re-
fine the gene module and lead to additional mechanistic
insight. For instance, Mootha et al (2003) noticed that not all
genes in the oxidative phosphorylation module were equally
downregulated in diabetes mellitus; the subset of genes
that were downregulated consisted of many known targets
of the transcriptional coactivator PGC-1a in muscle cells
(Mootha et al, 2003). Analysis of shared promoter elements
of genes that comprise the refined oxidative phosphorylat-
ion module has identified two transcription factors, estrogen
receptor related a and GA-repeat binding protein, as key
regulators that cooperate with PGC-1a to regulate expres-
sion of this gene module and cellular energy metabolism
(Mootha et al, 2004). Thus, gene module analysis has gen-
erated a model for impaired glucose tolerance and diabetes
mellitus in which the downregulation of PGC-1a function in
skeletal muscle results in the downregulation of genes in-
volved in oxidative phosphorylation.
Thirdly, gene module analysis has also been used for
exploratory discovery of the shared biological pathways
that underlie different human cancers. Using a strategy
termed Gene Module Map, Segal et al (2004) performed a
comprehensive analysis of 1975 previously published mic-
roarrays with 2849 gene modules. These gene modules
included tissue-specific genes, co-regulated genes, and
genes that function in the same process, act in the same
pathway, or share similar subcellular localization. Each mi-
croarray experiment was also annotated using a controlled
vocabulary for several hundred biological and clinical con-
ditions that it represents, including tumor type, stage, and
clinical outcomes. For each gene module and array, they
calculated the fraction of genes from that module that was
induced or repressed in that array and asked if this fraction
of enrichment was surprising based on chance alone, es-
timated using the hypergeometric distribution. A similar al-
gorithm was applied to the clinical annotations, and clinical
annotations that were enriched for each gene module were
identified.
In this fashion, the large number of microarray experi-
ments and their associated clinical information was distilled
to a core set of relationships that defined each cancer by a
specific combination of gene modules, many of which pro-
vide insight into molecular mechanisms underlying cancer
phenotypes. For example, poorly differentiated tumors of
many histologic types were found to share an activation of
the spindle checkpoint and M phase modules, which have
been previously associated with chromosomal instability
and aneuploidy. Many modules that were specific to par-
ticular types of cancer or even stages of the same disease
were also identified, such as deactivation of a growth in-
hibitory module of dual specificity phosphatases in acute
lymphoblastic leukemia and repression of an intermediate
filament module in breast cancers (Segal et al, 2004). Al-
though it is impressive that many of the newly described
relationships between gene modules and their respective
cancers can be supported by the literature, the significance
of the majority of gene modules in human cancers awaits
experimental validation.
Gene Modules Across Evolution
To truly assess the biological significance of gene modules,
one would need functional studies where one can perturb
gene co-expression and observe the biological effects. Are
such mutant organisms less fit across diverse environmen-
tal and physiologic conditions? In fact, this functional ex-
periment has been carried out in a comprehensive fashion
by evolution. The functional importance of co-regulated
genes can be gleamed by evolutionary conservation of their
co-expression in multiple organisms. Genes that must be
co-expressed together, such as genes that encode subunits
of the ribosome or the proteasome, will be under evolu-
tionary pressure to maintain their coordinated expression.
Thus, co-expression across evolutionary time can better
define functionally important sets of co-regulated genes
compared to using data from only a single species.
Stuart et al (2003) and Bergmann et al (2004) demon-
strate this concept by mapping all orthologues between
four and six species, respectively, and searched for coor-
dinate regulation of genes in the published microarray data
from humans, Drosophila, Caenhorhabditis elegans, Arab-
idopsis, Saccharomyces cerevisiae, and Escherichia coli.
These multi-species analyses defined new gene modules
based on co-expression across these diverse organisms.
Through this process, they discovered potential functions
for novel genes based on their co-expression with genes
that have known functions. They identified groups of co-
expressed genes that defined multiple essential cell proc-
esses; one of the largest identified by Stuart et al was a
module enriched for genes involved in the cell cycle and cell
proliferation. Based on evolutionary co-expression, novel
genes in this module are predicted to also have functions in
cell proliferation. Stuart et al selected a subset of the novel
genes for validation experiments in two different organisms.
The novel genes predicted to have functions in cell prolif-
eration genes were found to be overexpressed in human
pancreatic cancer relative to normal tissue, and RNA inter-
ference of one of these genes in C. elegans resulted in ex-
cess nuclei in the germ line, thus supporting its role in
regulating cell division. These results reinforce the concept
that systematic comparison of gene expression patterns
across diverse experiments and even organisms can high-
light the functional roles and molecular relationships be-
tween genes.
Genomic Methods of Hypothesis Testing
Expression profiling has previously been used as an ex-
ploratory research tool to suggest new models and hypoth-
eses. Expression profiling also can, however, be used for
hypothesis testing on a genome-wide scale (Lamb et al,
2003; Chang et al, 2004). Lamb et al used expression
profiling and gene module analysis to test alternative
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hypotheses of the oncogenic mechanism of cyclin D1 over-
expression in human cancer: the well-known effects of
activation of cyclin-dependent kinases (CDK), leading to
phosphorylation of Rb and derepression of E2F target
genes, versus alternative effects of CDK-independent ac-
tivation on gene expression. Lamb et al first identified an
expression profile of cultured human mammary epithelial
cells ectopically expressing cyclin D1 and defined the in-
duced genes in this experiment as a cyclin D1 gene module.
Interestingly, the cyclin D1 gene module did not include E2F
target genes and the expression signature was recapitulat-
ed by expression of a cyclin D1 mutant unable to activate
CDK4. Lamb et al used published datasets of global gene
expression patterns from 190 primary human tumors to de-
termine whether the cyclin D1 module defined in vitro was
found in human tumors. They ordered the expression pat-
tern of all genes in the genome according to its similarity to
the expression pattern of cyclin D1 across all of the tumors;
they then applied the Kolmogorov–Smirnov running sum
statistic to test if members of the cyclin D1 gene module
were overrepresented at the top of the list. The in vitro de-
fined cyclin D1 module correlated with cyclin D1 levels in
human tumors, but a module of known E2F target genes did
not, suggesting that in authentic human tumors, overex-
pression of cyclin D1 results in predominantly CDK-inde-
pendent effects. Lamb et al cloned a subset of the
promoters of genes in the cyclin D1 module, mapped the
sites of cyclin D1 responsiveness within these promoters
using reporter gene assays, and identified a sequence with
strong similarity to the consensus binding site of C/EBPb,
which was one of the most highly ranked genes in the cyclin
D1 module in human tumors. Cyclin D1 was found to in-
teract with C/EBPb and relieved transcriptional repression
by C/EBPb. Indeed, cyclin D1 could not transactivate its
target genes in C/EBPb-deficient cells, demonstrating that
C/EBPb is an essential transcriptional effector of cyclin D1.
Because overexpression of an inhibitory isoform of C/EBPb
in transgenic mice was also previously found to be onc-
ogenic (Zahnow et al, 2001), the gene module analysis,
combined with functional studies, have linked these two
pathways and suggests an alternative oncogenic mecha-
nism of cyclin D1 through C/EBPb in human cancers (Lamb
et al, 2003). In this instance, gene module analysis provided
the formal genetic evidence that cyclin D1 functions via the
C/EBP pathway in human cancers, and classic molecular
experiments provided mechanistic depth to how this con-
nection functions in vivo.
Similarly, Chang et al (2004) used a gene module ap-
proach to test the hypothesis that genes involved in wound
healing are reactivated in cancer progression. Based on the
idea that processes in the wound response such as cell
migration, matrix remodeling, and angiogenesis are well
suited to tumor cell invasion and metastasis, Chang et al
hypothesized that wound response genes may be evident in
a subset of cancers that are destined to become metastatic.
Because fibroblasts in vivo are exposed to serum, the sol-
uble fraction of clotted blood, only in the context of tissue
injury, Chang et al used detailed in vitro experiments to de-
fine a module of genes that characterized the response of
fibroblasts to serum exposure as a proxy for wound-healing
genes. The authors then compared the expression pattern
of the wound response module in approximately 500 pub-
lished global gene expression profiles of human tumors and
corresponding normal tissues, and found that the wound
response module was activated in a subset of human can-
cers from various tissues but not in their orthotopic normal
counterparts (Fig 2). In addition, primary tumors expressing
the wound response module were more likely to progress to
metastasis and death compared to tumors that did not (Fig
2). The best validation of a gene module’s prognostic value
is to test its ability to predict outcome in large independent
sets. Chang et al (2005) subsequently examined a database
of 295 breast cancer patients and found that the prognostic
power of the wound response gene module was reproduc-
ible in this independent set of patients. In early breast can-
cer, the wound response module was the most significant
predictor of metastasis compared to established clinical
and histologic criteria in multivariate analysis, highlighting
the wound response module as a powerful prognostic
marker (Chang et al, 2005). Thus, both Lamb et al and
Chang et al characterized gene modules of interest by
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Figure2
Wound response gene module predicts breast cancer progression.
(A) Expression of the fibroblast serum response genes in breast cancer
and benign breast samples reveals a biphasic pattern. The status of
serum regulation of each gene is shown on the right bar: red indicates
serum-induced; green indicates serum-repressed. Analysis reve-
als samples with expression of the serum-repressed genes (quiescent
group) and those with expression of the serum-induced genes (ac-
tivated group). The seven benign samples are indicated by orange
branches. (B) Validation of gene expression by in situ hybridization on
tissue microarrays. Expression of LOXL2, a fibroblast serum-induced
gene, on a 600 micron core of breast carcinoma is shown. LOXL2 is
expressed in stromal fibroblasts (stained brown) but not in tumor cells
(counterstained purple by hematoxylin), validating the expression array
data of an activated wound response signature. (C) Prognostic value of
wound response gene module. Kaplan–Meier survival curves of 78
breast cancer patients prospectively classified as having activated or
quiescent stroma. Patients were matched for age, histologic diagnosis,
and tumor stage and underwent the same treatment protocol. Tumors
with activated phenotype had significantly increased risk of metastasis
and mortality.
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expression profiling of in vitro model systems and then used
the resulting gene modules to query microarray data from
primary human tissue to test hypotheses about the genetic
pathways in human cancers. Both studies demonstrate the
ability of gene module analysis to provide novel and valu-
able insight into complex human diseases that are not
amenable to traditional genetic techniques.
Regulatory Networks
In many biological studies, we are interested in identifying
causal relationships—i.e., gene A is upstream of gene B and
induces B. Several investigators have applied probabilistic
graphical models, specifically Bayesian Networks, to iden-
tify regulatory relationships from static views of global gene
expression patterns (Segal et al, 2003; Beer and Tavazoie,
2004). Bayesian Networks are a particularly useful type of
model because they organize a set of variables into a hi-
erarchical model of conditional probabilities; the value of the
daughter variables are the joint conditional probability of the
parent variables. Typically, the model is used to evaluate
many combinations of specific variables, and particular
models that produce good fit of the data are validated by
additional computational and experimental tests (Friedman,
2004).
For example, because microarray data provide a global
view of mRNA abundance, the underlying regulatory net-
work could be the set of active transcription factors or the
set of promoter and enhancer elements that produced
the genome-wide transcriptional pattern. Segal et al ap-
proached this problem by reasoning that many transcription
factors and signal transducers are under transcriptional
control themselves; thus, a regulatory model may be con-
structed by relating the expression pattern of genes that
encode transcription factors to that of all other genes (Segal
et al, 2003). Segal et al developed a probabilistic Bayesian
algorithm, termed module networks, to identify the corre-
lations between the expression level of a manually curated
set of genes encoding transcription factors and signaling
proteins, termed regulators, and all other transcribed genes
(Segal et al, 2003). Transcribed genes were grouped
into modules based on the expression changes of the
regulators, and regulators were allowed to combine into hi-
erarchical patterns that were conditional, additive, or an-
tagonistic. Thus, unlike hierarchical clustering that only
identifies genes with similar patterns of expression, regu-
latory programs allowed logical operations such as AND,
OR, IF, and BUT. An iterative process of regulatory tree
building and gene module assignment is performed to opt-
imize both predictions. In each iteration, the procedure
learns the best regulation program for each module, and
given the inferred regulation programs, reassigns each gene
to the module whose program best predicts its behavior.
These two steps are iterated until convergence is reached.
This method has the advantage of generating testable hy-
potheses about gene modules and their regulatory pro-
grams in a single analysis. This method, however, is limited
by current biological knowledge because it relies on com-
piling a list of candidate regulators. In addition, although
this strategy can accommodate heterologous data such as
proteomic or enzyme activity profile data, currently most
high throughput data of regulators are transcriptional anal-
yses. Thus, the predicted regulatory trees can be wrong
because they fail to take into account post-transcriptional
and post-translational regulation.
To demonstrate the power of this strategy, Segal et al
(2003) used a set of 466 candidate regulators and a set of
173 arrays that measure responses of S. cerevisiae to var-
ious stresses, which resulted in 50 modules with regulation
trees. It should be noted that this type of algorithm will al-
ways produce a regulatory tree; the key assessment is the
quality of the regulatory trees and gene modules that are
produced. A good regulatory tree will encompass transcrip-
tion factors that are known to act or interact with one an-
other, and the gene modules will have member genes that
can be shown to have shared functions. Segal et al found
that thirty-one of the 50 modules had over 50 percent of its
genes with the same functional annotation, thirty of 50
modules included genes previously known to be regulated
by at least one of the module’s predicted regulators, and
fifteen of the 50 modules had a match between the cis-
regulatory motifs in the upstream regions of the module’s
genes and the regulator known to bind to that motif. This is
a rather remarkable feat given that the only input informa-
tion was gene expression data; no biochemical, genetic, or
sequence data was used to make the predictions. To further
validate this strategy, Segal et al chose three novel regu-
latory relationships predicted by the regulatory network
model, mutated each regulator, and performed global gene
expression analysis. In all three cases, the deletion mutants
selectively affected the gene modules that they were pre-
dicted to regulate. Thus, module networks is a useful meth-
od for generating hypotheses that can accurately predict
regulators, the processes that they regulate, and the con-
ditions under which they are active.
Hypotheses of regulatory mechanisms can also be gen-
erated from shared cis-regulatory DNA elements in the up-
stream regions of the genes in each module. Beer and
Tavazoie (2004) demonstrate a computational modeling
method for building regulatory networks based on these
regulatory DNA elements on a genome-wide scale. They
used a similar Bayesian probabilistic model to identify the
upstream DNA motifs that predict the expression pattern of
each gene module under different conditions. Beer and Ta-
vazoie demonstrate that prediction with DNA elements re-
quires complex rules because the expression level of a gene
is controlled by the occupancy states of multiple upstream
binding sites. They validated their regulatory network mod-
els by demonstrating that they correctly predicted the ex-
pression patterns of 73% of the genes using 20% leave-out
analysis. Although this cis-regulatory DNA elements method
would not reliably predict genes that are regulated by more
distant DNA elements or that have alternative regulatory
mechanisms such as chromatin modification, they demon-
strate that local upstream DNA sequence can predict gene
expression patterns of a large portion of genes, at least in
S. cerevisiae.
The large number of hypotheses generated from regu-
latory networks analysis or cis-regulatory DNA elements
analysis can be validated in a high throughput fashion using
chromatin-immunoprecipitation followed by microarray
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analysis (ChIP-chip) (Fig S1). ChIP-chip, initially described
by Ren et al (2000) and Iyer et al (2001) uses antibodies
specific to a candidate regulator for genome-scale chro-
matin-immunoprecipitation combined with microarrays
spotted with intergenic and promoter sequences to identi-
fy their bound targets. For example, Odom et al (2004)
demonstrate the use of antibodies to HNF1a, HNF4a, and
HNF6 to identify all genes that are bound by these tran-
scription factors in human liver and pancreas tissues, and
hybridized the immunoprecipitated chromatin fragments to
a custom microarray of over 10,000 human promoter se-
quences. These results revealed that a surprisingly large
fraction of genes transcribed in the liver and pancreas were
bound by HNF4a, providing a molecular explanation for the
role of HNF4a mutations and polymorphisms in hereditary
and sporadic forms of diabetes mellitus. In addition, as
mentioned above, regulator networks also can be validated
by expression profiling of mutants of the regulator to see if
its signature recapitulates the effect on the genes in the
module that it was predicted to regulate.
The power of these new bioinformatic methods relies on
a priori biological knowledge to compile gene modules,
functional annotations, and/or lists of candidate regulators.
Gene expression databases are publicly available that con-
tain many different expression profiles that show how
expression is altered by stress, disease, pharmaceuticals,
developmental stages, different growth conditions, and ge-
netic perturbations. The growing wealth of contributions to
these databases improves our ability to extract meaningful
information from microarray data and thus is a growing re-
source for future discoveries. This emphasizes the impor-
tance of unrestricted access to published microarray data
to the entire scientific community to reach the full potential
of scientific progress.
The post-genome era offers great promise toward our
understanding of the molecular mechanisms underlying hu-
man disease. As a result of the rapid advancement of bio-
informatic techniques, microarray analysis can be used for
both exploratory discovery and definitive hypothesis testing
to learn biologic pathways and their regulatory networks.
These analyses can then be validated with genome-wide
techniques such as ChIP-chip as well as traditional genetic
and biochemical experiments. Resources for these tech-
niques are readily available on the web (Table I). The inte-
gration of experimental and computational biology has the
potential to promote rapid advancement in the diagnosis,
prognosis, and treatment of human diseases.
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